BioSpace News Archive

Arix Bioscience plc (LSE: ARIX), a global healthcare and life science company supporting medical innovation, will announce its annual results for the period ended 31 December 2018 on Thursday, 28 March 2019.

Cell Mogrify Ltd (Mogrify), a UK company aiming to transform the future development of cell therapies, has won the ‘Disruptive Technology’ category at the Business Weekly Awards, in recognition of its novel bioinformatic platform, which is built upon a decade of world-class multidisciplinary science.

Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that its 2018 Annual Report together with the Notice of Annual General Meeting and the Form of Proxy have been posted to shareholders.

AB2 Bio Ltd, a Swiss advanced clinical-stage biotech company, specialized in developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, announced today that a single-arm open label design with a randomized withdrawal phase for its ongoing pivotal Phase 3 trial under an Investigational New Drug (IND) Application for its product candidate Tadekinig alfa, has been accepted by the U.S. Food and Drug Administration (FDA).

PACIFIC’s campaign for San Diego Blood Bank wins gold at American Advertising Awards

Access HealthNet, a Milwaukee-based startup and direct contracting solution for self-funded employers announced a partnership with Charlotte-based Direct Primary Care technology platform company, Beacon HealthCare Benefits.

With More Activities Than Any Previous Nintendo Labo Kit, Kids and Families Can Make, Play, Discover and Even Create Their Own VR Games

This weekend Madrid will host the 3rd edition of the world congress “Soft Tissue Sarcoma: Evidence and Experience”, where oncologists and medical specialists from all over the world will meet to share the latest advances in the treatment and diagnosis of this disease, which accounts for less than 1% of adult cancers.